Jennifer Jewelle Feldhaus, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 216 Dale Ave, Shelbyville, TN 37160 Phone: 931-684-9235 |
Dr. Nnamdi Ifeanyi Eze, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 120 Frank Martin Rd Ste 102, Shelbyville, TN 37160 Phone: 931-680-0602 Fax: 931-680-0654 |
Dr. Clifford L Garrard Jr., MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2839 Highway 231 N, Ste 208, Shelbyville, TN 37160 Phone: 931-685-5533 Fax: 931-685-5544 |
Clement F Bernard, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 841 Union St, Suite 101, Shelbyville, TN 37160 Phone: 931-685-4886 Fax: 931-685-6997 |
Thomas J Nedumthottathil, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 112 Airport Business Park Dr, Suite F, Shelbyville, TN 37160 Phone: 931-685-8620 Fax: 931-685-8621 |
Dr. Chris M. Marasco, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 112 Airport Drive, Suite H, Shelbyville, TN 37160 Phone: 931-680-6360 Fax: 931-680-9909 |
Dr. Ryan Michael Carr, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 120 Frank Martin Rd Ste 102, Shelbyville, TN 37160 Phone: 931-680-0602 Fax: 931-680-0654 |
Dr. Rachel Lynn Mitchell, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 120 Frank Martin Rd Ste 102, Shelbyville, TN 37160 Phone: 931-680-0602 Fax: 931-680-0654 |
News Archive
In today's Health on the Hill segment, Christine Vestal of Stateline joins KHN's Mary Agnes Carey and Jackie Judd to assess the progress - or lack thereof - states are making setting up insurance exchanges. They're required by the health law and they must be set up by 2014 to provide a online marketplace for people to buy insurance.
Scientists from the University of Granada have developed a new fluorescent dye capable of detecting, in a single test lasting 20 minutes, the presence of phosphate and biothiol inside living cells. This scientific breakthrough could contribute significantly to the early diagnosis of diseases such as osteoporosis, Alzheimer's, type 2 diabetes, and prostate cancer, since abnormal levels of both substances are associated with these diseases.
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that it has received notice from the U.S. Food & Drug Administration confirming an Orphan Drug Designation of BL-8040 as a treatment for stem cell mobilization, in addition to the Orphan Drug Designation previously granted to BL-8040 as a treatment for Acute Myeloid Leukemia.
The ability to perform simple daily tasks can make a big difference in people's lives, especially for those with spinal cord injuries.
Aerovance Inc. has announced that it has received clearance from the U.S. Food and Drug Administration (FDA) and the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate Aerovance's Phase IIb clinical trial, AeroTrial(TM), of inhaled dry powder Aerovant in patients with uncontrolled asthma.
› Verified 8 days ago